Info@ThinkPinkRocks.com

Posts Tagged targeted-therapy

What Is Epigenetics?

1 comment By Julie Grisham, MS, Science Writer/Editor   |  Tuesday, October 14, 2014 Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer. read more

For More........

Bold Initiative to Transform Cancer Care Established with a $100 Million Gift

5 comments By Eva Kiesler, PhD, Science Writer/Editor   |  Tuesday, May 20, 2014 With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology , Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.

For More........

Study Suggests Targeted Drug Is a Potential Therapy for Rare Joint Disorder PVNS

Add a Comment By Media Staff   |  Thursday, May 15, 2014 New Memorial Sloan Kettering research demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of a rare and debilitating joint disease.

For More........

At Work: Physician-Scientist David Solit

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Tuesday, May 27, 2014 David Solit , Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology , discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

For More........

At Work: Leukemia Specialist Martin Tallman

Add a Comment By Maureen Salamon, BA, Freelance Writer   |  Monday, May 19, 2014 Leukemia Specialist Martin Tallman discusses how research has led to improvements in the treatment of leukemia and what challenges remain.

For More........

Matters of the Heart: Newer Cancer Treatments Can Lead to Cardiac Problems

3 comments By Julie Grisham, MS, Science Writer/Editor   |  Wednesday, March 19, 2014 Cancer treatments, both traditional treatments and newer targeted therapies, can lead to short-term and long-term heart problems. read more

For More........

Comparison of Drugs for Advanced Kidney Cancer Suggests Side Effects Are More Manageable with Newer Option

Add a Comment By Maureen Salamon, BA  |  Thursday, August 22, 2013 An international study led by Memorial Sloan-Kettering found that pazopanib (Votrient ® ) controls cancer as effectively as sunitinib (Sutent ® ) while improving patients’ quality of life. read more

For More........
Page 1 of 3123